Statistics for BB Biotech AG (id:13037 BION)
Valuation metrics
Market cap
1.99B
Enterprise value
0.00
Trailing P/E (ttm)
15.85
Forward P/E
9.31
PEG ratio
9.31
Price/Sales (ttm)
-9.97
Price/Book (mrq)
Enterprise Value/Revenue
0.00
Enterprise Value/EBITDA
Overview
Shares outstanding
54.85M
Float
Shares short
% Held by insiders
% Held by institutions
Average volume (10 days)
111.90K
Average volume (90 days)
Price summary
52-Week low
35.45
52-Week high
49.80
52-Week change
-8.90%
Beta
50-Day moving average
37.09
200-Day moving average
41.09
Dividends and splits
Forward annual dividend rate
8.00
Forward annual dividend yield
0.22
Trailing annual dividend rate
2.00%
Trailing annual dividend yield
0.05
5-Year annual dividend yield
Payout ratio
Dividend date
March 27th, 2024
Ex-dividend date
March 25th, 2024
Last split factor
2:1
Last split date
March 29th, 2016
Financials
Fiscal yearFiscal year ends
December 31th, 2023
Most recent quarter (mrq)
September 30th, 2024
Profitability
Profit margin
Operating margin
Operational effectiveness
Return on assets
Return on equity
-8.89%
Income statement
Revenue (ttm)
-3.64
Revenue per share (ttm)
-3.64
Quarterly revenue growth (yoy)
Gross profit (ttm)
0.00
EBITDA
0.00
Net income to common (ttm)
-206,607,000.00
Diluted EPS (ttm)
-3.77
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
0.00
Total cash per share (mrq)
Total debt (mrq)
0.00
Total Debt/Equity (mrq)
0.00
Current ratio (mrq)
Book value per share (mrq)
40.70
Cash flow
Cash flow statement
Levered free cash flow (LFCF)
-206,607,000.00